ARL 17477 dihydrochloride (C09-0732-080)

Aladdin

Catalog No.: C09-0732-080
Manufacturer No.: A340387-50mg
Manufacturer Name: Aladdin Scientific
Quantity: 1
Unit of Measure: EA

Price: $625.08

List Price: $694.53

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account.

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

ARL 17477 dihydrochloride is a selective NOS1 (nNOS) inhibitor with IC|50|values of 1 and 17 μM for NOS1 and NOS3, respectively. This compound has been shown to reduce ischemic cell damage after middle cerebral artery (MCA) occlusion in rats. Furthermore, ARL 17477 dihydrochloride has been shown to display a synergistic neuroprotective effect when combined with either an NMDA or AMPA receptor antagonist. Molecular Formula: C20H20ClN3S•2HCl Molecular Weight: 442.83 PubChem CID: 9824646 Isomeric SMILES: C1=CC(=CC(=C1)Cl)CNCCC2=CC=C(C=C2)N=C(C3=CC=CS3)N.Cl.Cl Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/A340387-SCI_abd74ce9dbbe7b9be14bf899db15fe7b.pdf

UPC:: 12352107
Condition:: New
Availability:: 8-12 weeks
Weight:: 0.96 Ounces
HazmatClass:: No
WeightUOM:: LB
MPN:: A340387-50mg
CAS:: 180983-17-9
Product Size:: 50mg
Precautionary Statement Codes:: P264

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."